Hippocampal sclerosis in Alzheimer disease and other dementias
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Hippocampal sclerosis (HS) is defined as severe gliosis and neuronal loss in the CA1 region of the hippocampus and in the subiculum, with a wide range of severity and distribution.1,2 Its prevalence in autopsy series of demented elderly individuals ranged from 0.4 to 26%2,3 and was 7.4% in an autopsy cohort of prospectively evaluated demented elderly subjects,4 whereas it is extremely rare in nondemented patients considered the “oldest old.” In a recent series of 528 consecutive autopsies from the University of California at Los Angeles, 34 subjects (6.4%) with and without dementia—9.9% of demented and 3% of nondemented ones—showed HS. It was observed in Alzheimer disease (AD), frontotemporal dementia (FTD), vascular dementia (VaD), and Creutzfeldt–Jakob disease.5 Age at death was greater in demented subjects with than in those without HS (81.8 ± 12.5 vs …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohortN.S.M. Schoonenboom, F.E. Reesink, N.A. Verwey et al.Neurology, December 14, 2011 -
Article
Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer DiseaseDenis S. Smirnov, Douglas Galasko, Annie Hiniker et al.Neurology, March 15, 2021 -
Articles
The impact of apolipoprotein E4 on cause of death in Alzheimer's diseaseJ. M. Olichney, M. N. Sabbagh, C. R. Hofstetter et al.Neurology, July 01, 1997 -
Article
Hippocampal Sclerosis Contributes to Dementia in the ElderlyJ. Corey-Bloom, M. N. Sabbagh, M. W. Bondi et al.Neurology, January 01, 1997